Please assess the completion status of the following clinical trial:

Trial Title: Monitoring Parameters Beyond Glycemic Control: Impact of Sitagliptin on Quality of Life in Type 2 Diabetes Patients

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patient with Type 2 Diabetes mellitus between 18 to 65 years~* HbA1C 7% - 10%~* who can give informed consent.~* Patient uncontrolled on metformin and lifestyle modification from at least 3 months or who are metformin resistant~Exclusion Criteria:~* type 1 diabetes~* ≥1 episode of Diabetic Ketoacidosis and/or hyperosmolar hyperglycemic state,~* ≥1 episode of severe hypoglycaemia,~* Pregnant or lactating women,~* Pancreatitis,~* any serious complications or hypersensitivity

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- Uncontrolled Diabetes with Metformin or Metformin resistant (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).